EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 216 filers reported holding EDITAS MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $5 | -100.0% | 24,800 | -13.0% | 0.00% | -92.9% |
Q3 2022 | $207,000 | -87.6% | 28,500 | -76.3% | 0.01% | -83.1% |
Q2 2022 | $1,670,000 | -14.9% | 120,500 | -19.5% | 0.08% | +1.2% |
Q1 2022 | $1,962,000 | +51.2% | 149,731 | +58.0% | 0.08% | +127.8% |
Q4 2021 | $1,298,000 | -25.9% | 94,786 | -14.7% | 0.04% | -36.8% |
Q3 2021 | $1,752,000 | +81.9% | 111,068 | +13.9% | 0.06% | +90.0% |
Q2 2021 | $963,000 | -34.2% | 97,500 | -27.3% | 0.03% | -61.5% |
Q1 2021 | $1,463,000 | -17.6% | 134,183 | +82.0% | 0.08% | +52.9% |
Q4 2020 | $1,775,000 | +3380.4% | 73,725 | +381.9% | 0.05% | +1600.0% |
Q3 2020 | $51,000 | -72.6% | 15,300 | -92.5% | 0.00% | -70.0% |
Q2 2020 | $186,000 | -30.9% | 204,300 | +428.7% | 0.01% | -44.4% |
Q1 2020 | $269,000 | +126.1% | 38,645 | -81.4% | 0.02% | +157.1% |
Q4 2019 | $119,000 | -56.6% | 208,200 | +31.0% | 0.01% | -68.2% |
Q3 2019 | $274,000 | -46.3% | 158,911 | -4.6% | 0.02% | -43.6% |
Q2 2019 | $510,000 | -35.5% | 166,537 | -4.0% | 0.04% | -44.3% |
Q1 2019 | $791,000 | – | 173,517 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 7,101,935 | $55,395,093 | 2.14% |
Green Alpha Advisors, LLC | 77,188 | $602,066 | 0.46% |
Woodline Partners LP | 3,259,710 | $25,425,738 | 0.30% |
TANG CAPITAL MANAGEMENT LLC | 200,000 | $1,560,000 | 0.22% |
Spectrum Planning & Advisory Services Inc. | 14,038 | $109,496 | 0.17% |
PDT Partners, LLC | 156,515 | $1,220,817 | 0.15% |
CALTON & ASSOCIATES, INC. | 13,420 | $104,676 | 0.15% |
Corton Capital Inc. | 29,365 | $229,047 | 0.12% |
CAXTON ASSOCIATES LP | 61,223 | $477,539 | 0.07% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 119,287 | $930,439 | 0.06% |